Invention Grant
- Patent Title: Methods for identifying markers for early-stage human cancer, cancer progression and recurrence
- Patent Title (中): 识别早期人类癌症标志物,癌症进展和复发的方法
-
Application No.: US11529938Application Date: 2006-09-29
-
Publication No.: US08217222B2Publication Date: 2012-07-10
- Inventor: Mingxu Xu , Yuying Tan , Levy Kopelovich
- Applicant: Mingxu Xu , Yuying Tan , Levy Kopelovich
- Applicant Address: US CA San Diego US DC Washington
- Assignee: Anticancer, Inc.,The United States of America as represented by the Department of Health and Human Services
- Current Assignee: Anticancer, Inc.,The United States of America as represented by the Department of Health and Human Services
- Current Assignee Address: US CA San Diego US DC Washington
- Agency: Morrison & Foerster LLP
- Main IPC: G01N33/00
- IPC: G01N33/00 ; A01K67/00 ; A01K67/033 ; C12N5/00 ; C12N5/02 ; C12N15/00 ; C12N15/87

Abstract:
A method is described to identify secreted proteins identified with stages of malignancy of cancer. The proteins are initially identified by trapping them with a fluorescent protein containing vector that can insert in any gene. The secreted proteins are initially identified by their fluorescence. Secreted proteins identifying tumors with specific degrees of malignancy are isolated to determine if they can serve as markers of cancer progression.
Public/Granted literature
- US20070196821A1 Methods for identifying markers for early-stage human cancer, cancer progression and recurrence Public/Granted day:2007-08-23
Information query